SUMMARY Two haemagglutination tests using preserved turkey erythrocytes are described for the detection of thyroglobulin and microsomal antibodies, respectively. Comparative studies with the more traditional sheep cell techniques show good correlation of titres when testing sera from patients with autoimmune thyroid disorders.
Antibodies to thyroglobulin were first detected by a haemagglutination technique using fresh sheep cells treated with tannic acid (Witebsky and Rose, 1956 ). The technique was modified (Fulthorpe et al., 1961) using formalin as a preservative to improve the stability of the reagents. Microsomal antibodies have more traditionally been demonstrated by either complement fixation tests or immunofluorescence. More recently, microsomal activity has also been demonstrated by haemagglutination (Fujita and Yamada, 1970) using sheep cells coated with human thyroid microsomal proteins isolated from thyroid glands. Although sheep cells have been used reliably for many years, the use of avian cells as the carrier particle would seem to offer advantages of speed and specificity as demonstrated by their application to other HA systems (Sequeira and Eldridge, 1973; Cayzer et al., 1974) .
The present paper describes the production and evaluation of HA tests for the detection of thyroglobulin and microsomal antibodies using turkey in preference to sheep erythrocytes. Both 
THYROGLOBULIN
The thyroglobulin for cell sensitisation was isolated from human thyroids by fractionation of a saline extract with ammonium sulphate (Derrien et al., 1948) . Excess ammonium sulphate was removed from the partially purified thyroglobulin by dialysis against distilled water. The final preparation was stored frozen until required for sensitisation.
MICROSOMAL ANTIGEN
Thyroid glands taken from patients with Graves disease were immediately frozen and stored until required. The frozen glands were finely sliced with a scalpel, suspended in 0-15 M KCI, and homogenised in a Waring blender. The microsomes were separated from other cell debris by differential centrifugation using a modification of the technique described by Amino et al. (1976) . After sonication to obtain a soluble microsomal fraction the antigen was stored frozen until required for sensitisation.
CELL SENSITISATION
The formaldehyde-preserved cells were treated with tannic acid and then sensitised with either the thyroglobulin or microsomal antigen preparation. The levels of antigen that were required for sensitisation were determined by preliminary experiments covering a range of different antigen concentrations. The optimum proportions of cells and antigens were those which gave maximum sentivity when titrated against sera known to contain the corresponding 4L Cayzer, S. R. Chalmers, D. Doniach, and G. Swana antibodies, while at the same time retaining clarity of sedimentation patterns.
Unsensitised 'control' cells were prepared in the same manner, omitting the procedure of antigen sensitisation.
For long-term stability, test and control cells were preserved by lyophilisation.
SAMPLE DILUENTS

Thyroglobulin
The diluent used for titrating serum samples to be tested with the thyroglobulin-coated cells was isotonic saline containing 1 % normal turkey serum.
Microsome
In addition to normal turkey serum the microsomal cell diluent contained 0 1 mg/ml of a preparation of human thyroglobulin.
TEST PROCEDURES
Both haemagglutination tests were carried out using microtitration apparatus with rigid U-welled plates. For the thyroglobulin HA test, unheated serum samples were titrated in doubling dilutions using standard 0-025 ml volumes starting at a dilution of (102) 1:10. To each 0-025 ml of diluted serum was added 0-025 ml of sensitised cells. A control for each serum was included at a dilution of 1:10 by adding 0-025 ml of unsensitised cells. The microsomal HA test was performed by making fourfold dilutions of serum inactivated at 560C for 30 minutes, starting at a dilution of 1:100. To each 0-075 ml of diluted serum was added 0-025 ml of sensitised cells. Similarly, a control for each serum using unsensitised cells was included at the 1:100 dilution level. To evaluate the sensitivity and specificity of the two tests, samples were also tested by established, commercially available sheep cell reagents (Thyroglobulin Haemagglutination Test Kit from Wellcome Reagents, Beckenham, Kent; Microsome HA prepared by Fujizoki Pharmaceutical Co Ltd, Japan).
The Microsome HA test was also compared with the indirect immunofluorescence technique, using thyrotoxic thyroid glands as substrate. Test sera were applied for 20 minutes at room temperature followed by anti-human-Fab/FITC conjugate with 2 x 20 minute washes before and after the conjugate. Positive results obtained with undiluted test sera were subsequently titrated using serial serum dilutions starting at 1:10.
A little over 400 test samples were examined by the (Fig. 2) .
The latter method was performed according to the manufacturer's instructions using cells freshly reconstituted on the day of test. The results are expressed as the (square root)2 of the total reaction volume in the microtitre well. We have preferred to report our results on the turkey cell test as the dilution of the serum before the addition of cells.
There was good correlation between cytoplasmic immunofluorescence and microsomal haemagglutination titres, taking into account the 100-fold greater sensitivity of the HA test.
The comparison between immunofluorescence and microsomal HA was performed on a small selected group of samples covering a wide range of antibody titres. The correlation between the two test systems is shown in Fig. 3 Both test systems gave negative results with the majority of normal donors tested. The positive results obtained were generally of low titre, as might be expected in a small random population (Table) . Although the number of normal donors tested was small, the frequency of positive results (microsomal 7%, thyroglobulin 4Y) correlates well with data available on the prevalence of thyroid antibodies in the normal population (Tunbridge et al., 1977) . When comparing the titres observed in the three autoimmune thyroid disorders studied, the expected 
